Authors


Oriana Lerner

Latest:

Can Supplements Effectively Manage Hair Loss?

Data presented at the American Academy of Dermatology 2022 Annual Meeting shows what supplements can and cannot manage alopecia areata.


Alan Irvine, MD, DSc

Latest:

Assessing Quality of Life and AAD Research Considerations

Alan Irvine, MD, DSc, shares insights on the impact of ruxolitinib on quality of life in pediatric patients and 2024 AAD research presentations to take into consideration.


Sachin Shridharani, MD

Latest:

Phase 3 Trial Data Highlights Efficacy of OnabotulinutoxinA in Platysma Prominence

Sachin Shridharani, MD, discusses the results of a recent Allergan Aesthetics study exploring the efficacy of onabotulinumtoxinA in treating platysma prominence.


Michael Payette, MD, MBA, FAAD

Latest:

Discussion of Traditional and Novel GPP Treatment Modalities

An expert in dermatology shares his insights into the management considerations with traditionally utilized treatments for generalized pustular psoriasis and discusses the impact of a recent approval in this space.


Heidi Moawad, MD

Latest:

What You Need to Know About Mentoring Doctors

Defining the goals of the mentoring relationship can be useful to clarify expectations.


Kathryn Schlenker, DO

Latest:

Best Communication Practices to Explain Palliative Care Plans

Katie Schlenker, DO, emphasizes the importance of empathy during tough conversations with skin cancer patients with few to no treatment options left.


Christine Pham, PharmD

Latest:

Clascoterone cream 1% targets androgen receptors

The topical cream is the first acne drug with a new mechanism of action to win FDA approval in the last 40 years.


Sara M. Wilchowski, DMSc, PA-C

Latest:

Alternative Care Options for Inflammatory Diseases

Considering the whole patient is crucial in understanding how natural alternatives can improve the skin.


Rocco Serrao, MD

Latest:

Rocco Serrao, MD Looks Ahead to Bimekizumab’s Approval

We had the chance to catch up with Serrao before he took the stage and he explained why dermatology clinicians should keep their eyes on bimekizumab’s data and shared opportunities for further research.


Nichole Tucker

Latest:

LEAP-010 Study Discontinued for Patients with PD-L1-Expressing HNSCC

A coprimary end point in the phase 3 LEAP-010 study will not be met.


Howard Rogers, MD, PhD, FACMS

Latest:

Looking Ahead to the 2023 ACMS Meeting

The ACMS president and scientific program chair share opportunities to discover innovations in Mohs surgery during this weekend’s meeting.






Christopher G. Bunick, MD, PhD

Latest:

The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

Christopher Bunick, MD, PhD, delves into current data and guidelines to consider when creating custom treatment plans for patients with atopic dermatitis.


Brian Iriye, MD

Latest:

Considering consumerism in health care

Patients’ ability to choose can affect your practice.




Steven Dayan, MD, FACS

Latest:

Steven Dayan, MD, FACS: Prioritizing Patient Satisfaction in Cosmetic Dermatology

Steven Dayan, MD, FACS, first author behind a recent study involving high rates of patient satisfaction following treatment with botulinum toxin, discusses the importance of placing patient satisfaction at the forefront of cosmetic dermatology.


Neha Kinariwalla

Latest:

Looking at the scalp and nails during a skin exam is key

A presentation from the 2021 virtual American Academy of Pediatrics Conference & Exhibition urges including examination of the scalp and nails during any skin exam.


Dawn Eichenfield, MD, PhD

Latest:

Frontline Forum Part 4: Exploring Expert Perspectives on the Management of Acne Vulgaris

In the final part of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.





Amy Spizuoco, DO, FAOCD

Latest:

Amy Spizuoco, DO, FAOCD: Addressing STDs and Utilizing Dermatopathology With Care in Diverse Patient Populations

Spizuoco shares pearls from her sessions, "Infectious Diseases: The Story Behind STDs," and "Everything You Need to Know About Dermatopathology and the Dermatopathologist," from the Diversity in Dermatology conference.


Christine Blank

Latest:

Drug Price Hikes Already Found in 2023

List prices of 450 medications have increased 5% overall at the beginning of 2023. More price hikes are expected.


Marcella R. Aquino, MD, FACAAI

Latest:

Marcella R. Aquino, MD, FACAAI: Don’t Make a Rash Dx

Marcella R. Aquino details issues in differential diagnosis for rashes that mimic allergic skin conditions at the ACAAI Annual Meeting.


Matthew Reedy, MD

Latest:

Administrative Burden of Prescribing Biologics

Prescribing biologics can require a complex approval and claims process. Creating a tiered system based on office workload can help practices understand and allocate staff time. Outsourcing approvals to pharmacies where possible can also streamline the process.


© 2024 MJH Life Sciences

All rights reserved.